- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
A Multidisciplinary Approach to Managing Complexities in Cancer Care
As September marks National Ovarian Cancer Awareness Month, we sat down with ovarian cancer survivor Marion Roth and Vaagn Andikyan, MD, gynecologic oncologist, Western Connecticut Health Network, to discuss Marion's cancer journey and the importance of a multidisciplinary care team in treating complexities in cancer care.
In 2016, 56-year-old Marion Roth was diagnosed with a rare type of ovarian cancer. She had also been living with type 1 diabetes for nearly 48 years, bringing further complication to her diagnosis and a need for a multidisciplinary team to treat her. Throughout her cancer treatment, Marion was under the care of Vaagn Andikyan, MD, gynecologic oncologist, Western Connecticut Health Network, and Kevin Jain, MD, medical oncologist, Danbury Hospital, as well as Robert Savino, DO, endocrinologist, Western Connecticut Medical Group. Together, the multidisciplinary team collaborated to develop an effective and safe plan to treat Marion's cancer while also maintaining her diabetes treatment.
As September marks National Ovarian Cancer Awareness Month, we sat down with Marion and Dr Andikyan to discuss Marion's cancer journey and the importance of a multidisciplinary care team in treating complexities in cancer care.
To listen to the podcast, please login.
Listen above or or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Learn more about multidisciplinary cancer care, as well as management challenges and treatment options in ovarian cancer:
Dr Mark Soberman on the Next Generation Multidisciplinary Cancer Care Team
Dr Matthew Gubens: Multidisciplinary Approach Can Help Oncologists Tackle Immunotherapy Toxicities
Management Challenges in Ovarian Cancer
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
